• Skip to main content

Mobius Therapeutics

Dedicated to perioperative pharmaceuticals for ophthalmology

  • Home
  • Products
    • Product Lineup
    • Peri-Operative Resource Center
  • Place An Order
  • News
  • About Us
    • Company Profile
    • The Mobius Team
    • Terms of Use
    • Privacy Policy
    • Corporate Responsibility
  • Contact Us

Peri-Operative Ophthalmology

Legislative    Anesthetics

Legislative (DQSA, USP)

DQSA Law

Read the Drug Quality and Security Act (DQSA) law which grants the FDA regulatory authority over compounded drugs.

See the law
DQSA Law

FREE EDUCATIONAL RESOURCE

USP <800> Hazardous Drugs: Handling in Ophthalmic Healthcare Settings.

Download the Manual
DQSA Law

USP 800 NIOSH Alert

Both traditional medications and bioengineered drugs can be hazardous to health care workers who must handle them.  This NIOSH Alert will help make workers and employers more aware of these hazards and provide the tools for preventing exposures.

Read More
NIOSH Alert

Anesthetics

IJO Article – Hyaluronidase Clinical Trial

Results of a clinical trial investigating the effect of hyaluronidase usage on the quality of sub-Tenon’s anesthesia for phacoemulsification.

Read the article.
IJO Report

WMT-004 Rev 07/2022

© 2023 · Mobius Therapeutics